Overview

The actively managed equity fund focuses on bottom-up active stock selection across US markets.

The fund aims to invest in selected US companies, that trade below their long-term fair value based on fundamental analysis.

The fund is diversified across sectors.

It is a high conviction portfolio based on best-ideas across the US equity market with a clear Value bias.

The portfolio manager is not tied to the benchmark in terms of investment selection or weight.

Benefits

Easy access to US equity markets.

The portfolio may deviate considerably from the reference index in order to increase outperformance potential.

The fund managers leverage off a network of equity analysts in the US and around the globe.

Investors benefit from the fact that UBS is one of the few asset managers with a truly global investment platform.

Risks

UBS Opportunity Equity Funds invest in equities and may therefore be subject to high fluctuations in value. As these UBS Funds pursue an active management style, each Fund's performance can deviate substantially from that of its reference index. All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk). This Fund may not be appropriate for investors who plan to withdraw their money before the recommended holding period disclosed in the PRIIPs KID, if available for this share class.

Features

Product category
UBS Equity Funds
UBS Opportunity Equity Funds
Product domicile
Luxembourg
Portfolio management
UBS SA国际传谋 (UK) Ltd., London
Fund management
UBS SA国际传谋 (Europe) S.A., Luxembourg
Custodian bank
UBS Europe SE, Luxembourg Branch
Representative for products established under foreign law
BNP PARIBAS Securities Services
Day of inception
December 3, 2015
Currency of account
USD
Currency of unit class
EUR
Close of financial year
May 31
SFDR Classification
Art.6
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
1.03% p.a.
Management fee
0.76% p.a.
Total expense ratio (TER)
1.02% p.a.
Swing pricing
yes
Minimum investment
n.a.
Reference Index / Benchmark
MSCI USA (net div. reinv.) (hedged EUR)
ISIN
LU0358729571
Bloomberg Ticker
UBSUEBP LX

Performance and Prices

Percentage growth

as of April 23, 2026
Cumulative
EUR(%)
YTD 2.77
1M
3M
6M
1Y 32.98
2Y 21.79
3Y 45.50
5Y 34.53
ø p.a.5Y

Current data

Net asset value 23.04.2026 EUR 242.32
High - last 12 months 22.04.2026 EUR 244.26
Low - last 12 months 24.04.2025 EUR 186.96
Assets of the unit class in mn 23.04.2026 EUR 0.48
Total product assets in mn 23.04.2026 EUR 150.11
Statistical data
Date
2 years
5 years
Total risk reference index / benchmark 31.03.2026 11.43% 15.63%
Sharpe Ratio 31.03.2026 0.05 0.22
Risk Free Rate 31.03.2026 2.75% 1.89%

Structures

By the 10 largest equity positions (in %, as of March 31, 2026)

 
 
Alphabet Inc 7.62
Amazon.com Inc 6.03
NVIDIA Corp 5.98
Microsoft Corp 4.85
Broadcom Inc 3.13
Eli Lilly & Co 3.04
Apple Inc 2.81
First Horizon Corp 2.24
Bristol-Myers Squibb Co 2.12
Westlake Corp 1.95

Fees

Ongoing costs p.a.
1.03%
Flat fee
0.95%
Management fee p.a.
0.76%
Max. issuing commission
5.00%
Max. redemption commission
0.00%
Distribution fee
(see info)

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Australia
Institutional Only*
Austria
Registered
Belgium
Registered
Denmark
Registered
Finland
Registered
France
Registered
Germany
Registered
Greece
Registered
Hungary
Registered
Italy
Institutional Only*
Liechtenstein
Registered
Luxembourg
Registered
Netherlands
Registered
Norway
Registered
Singapore
Institutional Only*
Spain
Registered
Sweden
Registered
Switzerland
Registered
United Kingdom
Registered

Literature

Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Annual and semi-annual report (accounting on May 31)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.